Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1993-4-19
|
| pubmed:abstractText |
The clinical, parasitological, hematological, and serological evolution of visceral leishmaniasis in Brazilian patients was assessed during treatment with human recombinant interferon-gamma (rIFN-gamma; 0.1 mg/m2 i.m. days 1-14) followed by pentavalent antimony (Sbv; 10 mg/kg days 22-28). At day 30, 6 patients had improved, 2 had slightly improved, and 1 patient had deteriorated. IFN-gamma was well tolerated in the dose tested and may be very effective as an adjunct to conventional therapy with antimony.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0197-8357
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
13
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
39-41
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8454909-Adolescent,
pubmed-meshheading:8454909-Adult,
pubmed-meshheading:8454909-Antimony,
pubmed-meshheading:8454909-Child,
pubmed-meshheading:8454909-Child, Preschool,
pubmed-meshheading:8454909-Combined Modality Therapy,
pubmed-meshheading:8454909-Female,
pubmed-meshheading:8454909-Humans,
pubmed-meshheading:8454909-Interferon-gamma,
pubmed-meshheading:8454909-Leishmaniasis, Visceral,
pubmed-meshheading:8454909-Male,
pubmed-meshheading:8454909-Pilot Projects,
pubmed-meshheading:8454909-Recombinant Proteins
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony.
|
| pubmed:affiliation |
Landesinstitut für Tropenmedizin Berlin, Germany.
|
| pubmed:publicationType |
Journal Article
|